Stifel Financial Corp Trims Stock Position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Stifel Financial Corp lessened its holdings in Sabra Health Care REIT, Inc. (NASDAQ:SBRA - Free Report) by 18.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 501,258 shares of the real estate investment trust's stock after selling 113,245 shares during the period. Stifel Financial Corp owned about 0.21% of Sabra Health Care REIT worth $9,328,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of SBRA. Envestnet Asset Management Inc. raised its position in shares of Sabra Health Care REIT by 7.1% in the second quarter. Envestnet Asset Management Inc. now owns 579,110 shares of the real estate investment trust's stock valued at $8,918,000 after buying an additional 38,144 shares during the last quarter. Renaissance Technologies LLC grew its stake in Sabra Health Care REIT by 77.0% during the 2nd quarter. Renaissance Technologies LLC now owns 1,287,279 shares of the real estate investment trust's stock valued at $19,824,000 after acquiring an additional 559,800 shares in the last quarter. Texas Permanent School Fund Corp raised its holdings in Sabra Health Care REIT by 22.1% in the 2nd quarter. Texas Permanent School Fund Corp now owns 247,000 shares of the real estate investment trust's stock valued at $3,804,000 after acquiring an additional 44,639 shares during the last quarter. Asset Management One Co. Ltd. lifted its stake in Sabra Health Care REIT by 14.2% in the 3rd quarter. Asset Management One Co. Ltd. now owns 539,004 shares of the real estate investment trust's stock worth $10,031,000 after purchasing an additional 66,929 shares in the last quarter. Finally, Citigroup Inc. boosted its holdings in shares of Sabra Health Care REIT by 104.0% during the 3rd quarter. Citigroup Inc. now owns 316,007 shares of the real estate investment trust's stock worth $5,881,000 after purchasing an additional 161,071 shares during the last quarter. Institutional investors and hedge funds own 99.40% of the company's stock.

Sabra Health Care REIT Stock Down 1.8 %

Shares of SBRA stock traded down $0.31 during trading hours on Thursday, reaching $17.37. 1,829,638 shares of the stock were exchanged, compared to its average volume of 2,039,768. The business's fifty day moving average is $18.53 and its two-hundred day moving average is $17.05. The firm has a market capitalization of $4.11 billion, a P/E ratio of 42.37, a P/E/G ratio of 2.26 and a beta of 1.24. Sabra Health Care REIT, Inc. has a 12-month low of $12.83 and a 12-month high of $20.03. The company has a debt-to-equity ratio of 0.90, a current ratio of 4.16 and a quick ratio of 4.16.

Sabra Health Care REIT (NASDAQ:SBRA - Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.13 EPS for the quarter, missing analysts' consensus estimates of $0.35 by ($0.22). The firm had revenue of $178.00 million during the quarter, compared to analysts' expectations of $177.19 million. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. During the same period in the prior year, the company posted $0.34 earnings per share. As a group, research analysts expect that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current fiscal year.

Sabra Health Care REIT Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 29th. Stockholders of record on Friday, November 15th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.20 annualized dividend and a dividend yield of 6.91%. Sabra Health Care REIT's dividend payout ratio is currently 292.68%.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on the company. Scotiabank boosted their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a "sector perform" rating in a research note on Friday, October 11th. Wells Fargo & Company upgraded shares of Sabra Health Care REIT from an "equal weight" rating to an "overweight" rating and raised their price objective for the stock from $16.00 to $20.00 in a research report on Tuesday, October 1st. Mizuho reiterated a "neutral" rating and issued a $20.00 price objective on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Citigroup upgraded shares of Sabra Health Care REIT from a "neutral" rating to a "buy" rating and lifted their price target for the company from $17.00 to $20.00 in a research report on Friday, September 13th. Finally, Truist Financial boosted their price objective on Sabra Health Care REIT from $16.00 to $18.00 and gave the company a "buy" rating in a report on Wednesday, September 4th. Two equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, Sabra Health Care REIT currently has a consensus rating of "Moderate Buy" and an average target price of $19.14.

Sabra Health Care REIT Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.